reports
NBT Bancorp Inc. Announces Date of Second Quarter Conference Call
NBT Bancorp Inc. Announces Date of Second Quarter Conference Call NORWICH, N.Y., July 01, 2025 (GLOBE NEWSWIRE) -- NBT Bancorp Inc. (“NBT” or the “Company”) (NASDAQ: NBTB) will release details of its financial results for the second quarter 2025 on Monday, July 28, 2025, following the market close. The Company will host a conference call at 10:00 a.m. (Eastern) Tuesday, July 29, 2025, to review these results. The audio webcast link, along with the corresponding presentation slides, will be available on the Company’s Event Calendar page at prior to the beginning of the conference call. T...
- David Nierengarten
- Dennis Pak
- Martin Fan
- Wedbush Research
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
RARE ULTRAGENYX PHARMACEUTICAL INC.
PRGS PROGRESS SOFTWARE CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
GOOGL ALPHABET INC. CLASS A
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
PTGX PROTAGONIST THERAPEUTICS
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
BUR BURFORD CAPITAL
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
FTI Consulting Appoints Joseph Shipley to Lead Private Equity Offering...
FTI Consulting Appoints Joseph Shipley to Lead Private Equity Offering within the Strategic Communications Segment in London and across EMEA LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Joseph Shipley as a Senior Managing Director within the Strategic Communications segment, where he will lead the firm’s work with private equity clients and their portfolio companies in London and across the Europe, Middle East and Africa (“EMEA”) region. Mr. Shipley, who is based in London, has been a trusted senior advisor to boards, with ...
- David Nierengarten
- Dennis Pak
- Dylan Shindler
- Laura Chico
- Martin Fan
- Ritika Das
- Robert Driscoll
- Yun Zhong
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
FRX_CN FENNEC PHARMACEUTICALS
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
APGE APOGEE THERAPEUTICS INC
Banking and Payments Expert Joins FTI Consulting as Senior Managing Di...
Banking and Payments Expert Joins FTI Consulting as Senior Managing Director WASHINGTON, D.C., June 30, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of banking and payments expert as a Senior Managing Director in the Financial Services practice within the Forensic and Litigation Consulting segment. Mr. Allen, who is based in Charlotte, has more than 30 years of experience in financial services, in both industry and advisory positions, supporting payment strategy, customer experience and operations modernization. In his role at FTI Consultin...
- Blair Levin
- Jonathan Chaplin
- Blair Levin
Translating Carr on SATS
Yesterday, at the post FCC open meeting press conference, Chairman Carr made some comments about the situation with SATS. In this note, we report on the comments as well as providing a translation, as the words on their face do not indicate where he thinks the process is heading but they do, if interpreted properly, indicate where he would like it to go. In addition, we tie Carr’s comment to the Bloomberg report that Ergen is seeking a 30-day reprieve from creditors.
- Blair Levin
As SATS Chapter 11 Clock Clicks Down, Does FCC Need to Act?
On May 30th, SATS declined to make an $326 million interest payment. Given the automatic 30-day grace period, that means SATS must either make the payment by June 30th or it goes into default. Per President’s Trump’s instructions, Chairman Carr is supposed to be negotiating with Charlie Ergen to see if there is a path to avoid bankruptcy. In this note we discuss what we know and cannot know about those negotiations.
FTI Consulting Survey: Majority of Private Equity Leaders Say M&A Is N...
FTI Consulting Survey: Majority of Private Equity Leaders Say M&A Is Not a Top Priority for 2025 WASHINGTON, June 24, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today released the 2025 , which found that M&A ranked last among 10 value creation levers, with only 9% of global private equity leaders naming it their top priority for 2025. The survey of more than 500 global private equity decision makers highlights ways in which firms continue to over index on conventional cost levers — such as cost structure optimization, supply chain and operations — which are widely used a...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
RMAX RE/MAX HOLDINGS INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
MDLZ MONDELEZ INTERNATIONAL INC. CLASS A
LOCO EL POLLO LOCO HOLDINGS INC
DIN DINE BRANDS GLOBAL INC.
MSGS MADISON SQUARE GARDEN SPORTS CORP. CLASS A
TCI TRANSCONTINENTAL REALTY INVESTORS INC
RDFN REDFIN CORPORATION
NANX NANOPHASE TECHNOLOGIES CORP.
BH BIGLARI HOLDINGS B
PAYS PAYSIGN INC
BBIO BRIDGEBIO PHARMA
VIAC VIACOMCBS INC. CLASS B
HIMS HIMS AND HERS HEALTH INC (A)
OSCR OSCAR HEALTH
LMND LEMONADE INC
ASTS AST SPACEMOBILE INC
SRM SRM ENTERTAINMENT INC
LGCY LEGACY EDUCATION INC.
BATRA LIBERTY MEDIA CORPORATION
OXOTECH OXO TECHNOLOGIES HLDG PLC
PHH PARK HA BIOLOGICAL TECHNOLOGY CO. LTD.
- Blair Levin
- Jonathan Chaplin
Mobile and broadband pair trades to consider this summer
While we have been intensively focused on such things as a Presidential intervention to prevent a Chapter 11, we admit that our mind occasionally drifts to thoughts of summer. So to help others who may have similar thoughts, we thought, in honor of summer beginning, we should provide our thoughts as to which alcohols pair best with the purchase of the stocks we cover (actually, we just asked ChatGPT and, given its attitude about intellectual property, we have no fears about just cutting and pas...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Semiconductors and Technology Leading the Way We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass). We will maintain our bullish view as long as market dynamics remain healthy and the S&P 500 (SPX) is above 5700-5785 (up from 5500). We continue to be buyers in the 5700-5785 range if it gets there, and we would also be buyers at 5804-5854 gap support. We are expecting all-time highs soon on the SPX. Technolo...
LPG DORIAN LPG
G2O GOLAR LNG LIMITED
RIGN TRANSOCEAN LTD.
TRT1 TRANSATLANTIC PETROLEUM LTD.
INSW INTERNATIONAL SEAWAYS INC.
SMH MARKET VECTORS SMEICONDOUCTOR ETF
SDRL SEADRILL LTD.
STNG SCORPIO TANKERS INC.
VAL VALARIS LTD
ALCC ALTC ACQUISITION CORP
SMR NUSCALE POWER CORP
FRO FRONTLINE PLC
NE NOBLE CORP (NEW)
NNE NANO NUCLEAR ENERGY
TNK SEADRILL LTD
CPLPB TEEKAY TANKERS LTD.
TK CARGOPORT LOGISTICS CA PFD B
TEEKAY CORPORATION LTD.
- Blair Levin
Trump Mobile: Just Another MVNO or Game Changer?
As we noted Friday, the Trump Organization is entering the mobile services market. Our New Street colleagues have published a note comparing the Trump offering to other wireless services. In this policy focused note we discuss the potential relationship with the SATS proceedings, the potential conflicts of interests, the track record of such Trump consumer offerings, the potential conflicts of interests, and how regulation could shape MVNO and wireless markets.
- Blair Levin
SATS v. Carr State of (the) Play: Curtain Raises on Act II
Last Friday, Bloomberg reported on a meeting at the White House between the President, FCC Chair Carr and EchoStar Chair Charlie Ergen. We provided quick thoughts on the implications of the meeting Friday afternoon. In this note we update our overall analysis on where the conflicts between Carr and SATS stands and how we think those issues will play out post the Presidential involvement.
- Jonathan Chaplin
SATS: Trump intervenes; Ergen files for extensions
Two pieces of news broke just in time for you to ponder over cocktails. First, Bloomberg reported that Trump met with Ergen and Carr at the White House yesterday, urging them to make a deal. Second, EchoStar filed “prophylactically” for license extensions, in the event that the V-Tel petition is granted. Some musings, but not much substance in this note.
- Blair Levin
SATS Update: POTUS, Ergen and Carr and More
Just as we were getting ready for the weekend, three data points came across our screen involving SATS, including one about a meeting between President Trump, Ergen, and Carr. In this note, we provide a quick summary of the data point and our quick response.
- Jonathan Chaplin
- Blair Levin
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.